OMER News and Press, Omeros Corporation From 08/21/20

The S&P 500 made new, all-time highs this week. Yet, many stocks are struggling. This is a red flag and harbinger of future weakness. Assured Guaranty (AGO), Omeros (OMER), Dynavax Technologies (DVAX), Flexion Therapeutics (FLXN), and Children's Place (PLCE) are five stocks downgraded by th...

When I last wrote on Omeros ( OMER ) earlier this month, I did not expect to be revisiting so soon; however, its press release issued with its Q2 2020 earnings has scrambled the situation in a good way. This article reports on the several significant changes since my earlier article and ex...

Shares of Omeros   (NASDAQ: OMER) fell as much as 13.3% today after the company announced the pricing of a public offering of common stock and more details about a debt offering.  The biopharma will offer up to 7.9 million shares of common stock at $14.50 apiece, which would haul in...

Staffing 360 Solutions (NASDAQ: STAF )   -21%  on Q2 earnings . More news on: Staffing 360 Solutions, Inc., Jumia Technologies AG, Super League Gaming, Inc., Stocks on the move, , Read more ...

Omeros (NASDAQ: OMER ) has priced its public offering of 6.9M shares of common stock at $14.50 per share. Underwriters' overallotment is an additional ~1M shares. More news on: Omeros Corporation, Healthcare stocks news, , Stocks on the move, Read more ...

--6,900,000 Shares of Common Stock-- --$210,000,000 of 5.25% Convertible Senior Notes due 2026-- Omeros Corporation (Nasdaq: OMER) (“Omeros”) today announced that it has priced concurrent underwritten public offerings of 6,900,000 of shares of its common stock (the &#x...

Reata Slips on operational updates including omaveloxolone setback Reata Pharmaceuticals Inc. ( RETA ) announced its second quarter financial numbers and provided an update for its business operations. However, the markets reacted negatively to the news, leading the company stock to plun...

Fennec Pharmaceuticals (NASDAQ: FENC )   -31%  on FDA rejection of Pedmark application. More news on: Fennec Pharmaceuticals Inc., Mesoblast Limited, Genesis Healthcare, Inc., Stocks on the move, , Read more ...

Omeros (NASDAQ: OMER )   rallied 50.9%  today after reporting positive results from a compassionate-use study evaluating narsoplimab (OMS721) in severely ill COVID-19 patients with acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. More news on: Omero...

Omeros (NASDAQ: OMER ) : Q2 GAAP EPS of -$0.61 misses by $0.02 . More news on: Omeros Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...